These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
1/3/2019
1:26 PM ET
Press Release

Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference

1/3/2019

WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at...

 Continue Reading
11/1/2018
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2018 Financial Results

11/1/2018

Record quarterly revenue of $49.5 million represents 35% year-over-year growth Revenue guidance raised to $191-$194 million for full year 2018 WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Repli...

 Continue Reading
10/22/2018
7:30 AM ET
Press Release

Repligen to Report Third Quarter 2018 Financial Results

10/22/2018

- Webcast and Conference Call to Be Held Thursday, November 1, 2018 at 8:30 a.m. EDT -

WALTHAM, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced...

 Continue Reading
9/4/2018
11:05 AM ET
Press Release

Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

9/4/2018

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technologyCustomers to benefit from simplified, scalable solut...

 Continue Reading
8/2/2018
7:30 AM ET
Earnings Release

Repligen Reports Second Quarter 2018 Financial Results

8/2/2018

Record quarterly revenue of $47.7 million represents 47% year-over-year growth Revenue guidance raised to $185-$190 million for full year 2018 WALTHAM, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Repli...

 Continue Reading
Displaying 1 to 5 (of 222 releases)